← Back to catalogue
Cellstor - 1l - 10% Neutral Buffered Formalin
EUDAMEDClass A (EU MDR)
Ref BAF-0010-01ARef BAF-0010-01CRef BAF-0010-01DRef BAF-0010-01Y
by CellPath Ltd
Identity
- Trade Name
- CELLSTOR - 1L - 10% NEUTRAL BUFFERED FORMALIN EUDAMEDCELLSTOR – 1L – 10% NEUTRAL BUFFERED FORMALIN EUDAMED
- Device Name
- 10% NEUTRAL BUFFERED FORMALIN EUDAMED
- Model / Reference
- BAF-0010-01A EUDAMEDBAF-0010-01C EUDAMEDBAF-0010-01D EUDAMEDBAF-0010-01Y EUDAMED
Identifiers
- Primary DI / UDI-DI
- 05056256112979 EUDAMED05056256110470 EUDAMED05056256110487 EUDAMED05056256104998 EUDAMED
- Basic UDI-DI
- 05056256BAF002VY EUDAMED
- EMDN Code
- W01030705 FIXING REAGENTS (HISTOLOGY/CYTOLOGY) EUDAMED
Classification
- Device Class
- Class A EUDAMED
- Market of Registration
- Netherlands EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Microbial Substances
No
EUDAMED
Reagent
No
EUDAMED
Self Testing
No
EUDAMED
Near-Patient Testing
No
EUDAMED
Professional Testing
No
EUDAMED
Companion Diagnostics
No
EUDAMED
Surgical Instrument
No
EUDAMED
New Device
No
EUDAMED
Cellstor - 1l - 10% Neutral Buffered Formalin by CellPath Ltd — Class A — IVDR — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/IVDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/IVDR | 05056256BAF002VY | Class A | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- CellPath Ltd
- EUDAMED SRN
- GB-MF-000022744
- Authorised Representative
- Emergo Europe B.V. NL-AR-000000116
Sources (4)
- EUDAMED ec817ef4-e592-407c-8fbe-44b519a87d32 61 fields · synced Aug 4, 2026
- EUDAMED 9ebd9765-a118-4c2e-916d-0b9d2183fc4e 61 fields · synced May 18, 2026
- EUDAMED 000b252b-4a5e-4158-8065-1bffa0dd52cd 61 fields · synced May 18, 2026
- EUDAMED 1e54e073-8d7e-4408-a93b-df6d0af79ef9 61 fields · synced May 18, 2026